November 23, 2016 - By Vivian Park
The Sr. VP & Chief Scientific Off. of Innoviva Inc, Theodore Witek is in the stock market news today. It was disclosed in a form filled by Theodore Witek and submitted to the D.C. based-SEC on 22-11-2016, he unloaded 3,700 shares from the Pinksheet-listed Innoviva Inc having an approx. value of $40,123 U.S Dollars. Theodore Witek’s shares average price was $10.8. Theodore Witek now has ownership of 0.14% of Innoviva Inc’s total market cap with ownership of 153,431 shares.
The stock decreased 0.09% or $0.01 during the last trading session, hitting $10.91. About 621,247 shares traded hands. Innoviva Inc (NASDAQ:INVA) has declined 20.64% since April 20, 2016 and is downtrending. It has underperformed by 25.20% the S&P500.
Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The company has a market cap of $1.19 billion. The Firm is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It has a 34.4 P/E ratio. The Company’s portfolio focuses on the respiratory assets partnered with Glaxo Group Limited , including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)).
According to Zacks Investment Research, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.”
More recent Innoviva Inc (NASDAQ:INVA) news were published by: Streetinsider.com which released: “Form 3 Innoviva, Inc. For: Nov 18 Filed by: Duncan Barbara Gayle” on November 21, 2016. Also Seekingalpha.com published the news titled: “Innoviva: On Track To Buy Back The Whole Company” on February 04, 2016. Streetinsider.com‘s news article titled: “GlaxoSmithKline (GSK), Innoviva (INVA) Announce Filing of FF/UMEC/VI ..” with publication date: November 21, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park